Remove 2008 Remove Communication Remove FDA
article thumbnail

Radical Transparency or Radical Redundancy? FDA Publishes 200+ Complete Response Letters, Most of Which Are Already Public

The FDA Law Blog

Butler — In a move FDA is calling “radical transparency,” the Agency announced on July 10, 2025 that it has published 200+ Complete Response Letters (CRLs) issued in response to marketing applications for drugs and biologics on its openFDA database. By Sarah Wicks & Michelle L.

FDA
article thumbnail

EpiPen patent expiry opens new era for innovation

Pharmaceutical Technology

The lawsuit contested that prices for a two-pack of EpiPens rose from around $100 in 2008 to $600 during the class period between March 2014 and February 2025. In January 2025, Mylan reached a $73.5m GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Uruguay progresses towards developing its first regulatory agency

Pharmaceutical Technology

Since 2008, the Association of Chemistry and Pharmacy of Uruguay has played an active role in promoting a National Health Surveillance Agency, and in 2020 the government attempted to launch a similar agency but it ultimately failed. Give your business an edge with our leading industry insights.

article thumbnail

Who is Dr. George Tidmarsh, the new director of CDER?

PharmaVoice

Despite past criticism of public health policies, Tidmarsh recently praised the FDA and said he’ll focus on boosting review efficiencies. But his history as a physician, academic, biotech entrepreneur and importantly, his blossoming ties to the FDA’s new band of leadership, were enough to land him a top post at the agency.

FDA
article thumbnail

Show 1337: Pros and Cons of LASIK Eye Surgery

The People's Pharmacy

FDA Considers New Warnings on LASIK Eye Surgery: The FDA first approved the laser devices for this procedure in 1999. Consequently, he petitioned the FDA to issue a Public Health Advisory regarding LASIK-related injuries. The FDA understands LASIK is safe and effective for those who are good candidates.

FDA
article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

The FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. The only schedule III-V narcotic drug that is currently approved by the FDA for OUD treatment is buprenorphine. By Karla L. 21 U.S.C. § 21 U.S.C. §

article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

According to the FDA, there are over 20,000 medications approved. A survey cited 1 by HealthIT.gov says with sources dating 2008-2012 and reviewed in 2019 says: 94% of providers report that their EHR makes records readily available at the point of care. Adverse drug events are avoided.